
NextGeM Inc. is a biopharma venture focused on regenerative medicine innovation through the fusion of advanced bio and digital technologies. They specialize in developing next-generation therapies using hematopoietic stem cells, aiming to create effective treatments with fewer side effects. The company also leverages AI and bioinformatics for new diagnostic and therapeutic methods, actively collaborating with domestic and international organizations. Their vision is to establish a platform where researchers can thrive, contributing to societal well-being and advancing healthcare globally. They are committed to addressing unmet medical needs in areas like rare diseases, infertility treatments, and drug-resistant infections, aligning with SDGs 3, 8, and 9.

NextGeM Inc. is a biopharma venture focused on regenerative medicine innovation through the fusion of advanced bio and digital technologies. They specialize in developing next-generation therapies using hematopoietic stem cells, aiming to create effective treatments with fewer side effects. The company also leverages AI and bioinformatics for new diagnostic and therapeutic methods, actively collaborating with domestic and international organizations. Their vision is to establish a platform where researchers can thrive, contributing to societal well-being and advancing healthcare globally. They are committed to addressing unmet medical needs in areas like rare diseases, infertility treatments, and drug-resistant infections, aligning with SDGs 3, 8, and 9.